Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency.
Autor: | Arsov T; Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia., Mullen SA, Damiano JA, Lawrence KM, Huh LL, Nolan M, Young H, Thouin A, Dahl HH, Berkovic SF, Crompton DE, Sadleir LG, Scheffer IE |
---|---|
Jazyk: | angličtina |
Zdroj: | Epilepsia [Epilepsia] 2012 Dec; Vol. 53 (12), pp. e204-7. Date of Electronic Publication: 2012 Oct 25. |
DOI: | 10.1111/epi.12007 |
Abstrakt: | Glucose transporter 1 (GLUT1) deficiency caused by mutations of SLC2A1 is an increasingly recognized cause of genetic generalized epilepsy. We previously reported that >10% (4 of 34) of a cohort with early onset absence epilepsy (EOAE) had GLUT1 deficiency. This study uses a new cohort of 55 patients with EOAE to confirm that finding. Patients with typical absence seizures beginning before 4 years of age were screened for solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1) mutations or deletions. All had generalized spike-waves on electroencephalography (EEG). Those with tonic and/or atonic seizures were excluded. Mutations were found in 7 (13%) of 55 cases, including five missense mutations, an in-frame deletion leading to loss of a single amino acid, and a deletion spanning two exons. Over both studies, 11 (12%) of 89 probands with EOAE have GLUT1 deficiency. Given the major treatment and genetic counseling implications, this study confirms that SLC2A1 mutational analysis should be strongly considered in EOAE. (Wiley Periodicals, Inc. © 2012 International League Against Epilepsy.) |
Databáze: | MEDLINE |
Externí odkaz: |